Journal
JCI Insight
Publication Date
11-8-2022
Volume
7
Issue
21
First Page
e162695
Document Type
Open Access Publication
DOI
10.1172/jci.insight.162695
Rights and Permissions
Schmitt EG, Toth KA, Risma SI, Kolicheski A, Saucier N, Berríos RJF, Greenberg ZJ, Leiding JW, Bleesing JJ, Thatayatikom A, Schuettpelz LG, Edwards JR, Vogel TP, Cooper MA. A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in mice. JCI Insight. 2022 Nov 8;7(21):e162695. doi: 10.1172/jci.insight.162695. © 2022, Schmitt et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.
Recommended Citation
Schmitt, Erica G; Toth, Kelsey A; Risma, Samuel I; Kolicheski, Ana; Saucier, Nermina; Berríos, Rafael J. Feliciano; Greenberg, Zev J.; Leiding, Jennifer W.; Bleesing, Jack J.; Thatayatikom, Akaluck; Schuettpelz, Laura G.; Edwards, John R.; Vogel, Tiphanie P.; and Cooper, Megan A, "A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in mice." JCI Insight. 7, 21. e162695 (2022).
https://digitalcommons.wustl.edu/oa_4/640